Ledger.Open graph →
SEC Form D · filed November 3, 2023

Centerline Biomedical, Inc

Offering
$12.7M
Sold
$12.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CLEVELAND, OH
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Gulam Khan · Cleveland, OHExecVikash K. Goel · Cleveland, OHExecJim N. Zalar · Cleveland, OHDirectorJai N. Gupta · Cleveland, OHDirectorVinod K. Goel · Cleveland, OHExec · DirectorPhil N. Rackliffe · Cleveland, OHExec · DirectorVikash K. Goel · Cleveland, OHExecVinod K. Goel · Cleveland, OHExec · DirectorJai N. Gupta · Cleveland, OHDirectorGulam Khan · Cleveland, OHExecJim N. Zalar · Cleveland, OHDirectorPhil N. Rackliffe · Cleveland, OHExec · DirectorJames R. Mccaffrey · Alpharetta, GAExecEdward C. Copelin · Alpharetta, GAExec · DirectorJacob Claver · CANTON, TXExecYaron C. Ashkenazi · Scottsdale, AZExec · DirectorNate Dapore · Coconut Grove, FLDirectorChristina Gibbs · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗